The Malaghan Institute of Medical Research in collaboration with Wellington Zhaotai Therapies Limited today announced results of its phase 1 dose escalation trial of a new third generation anti-CD19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback